Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$1.9 - $3.05 $406 - $652
-214 Reduced 2.2%
9,506 $27,000
Q2 2023

Aug 09, 2023

BUY
$1.47 - $2.56 $14,288 - $24,883
9,720 New
9,720 $18,000
Q4 2022

Feb 09, 2023

BUY
$0.93 - $1.52 $11,278 - $18,433
12,127 Added 36.8%
45,084 $52,000
Q3 2022

Nov 09, 2022

SELL
$1.1 - $2.06 $62,372 - $116,806
-56,702 Reduced 63.24%
32,957 $36,000
Q2 2022

Aug 11, 2022

BUY
$1.6 - $3.99 $25,464 - $63,500
15,915 Added 21.58%
89,659 $143,000
Q1 2022

May 12, 2022

BUY
$2.8 - $3.96 $94,038 - $132,996
33,585 Added 83.63%
73,744 $265,000
Q4 2021

Feb 11, 2022

SELL
$3.63 - $6.13 $20,832 - $35,180
-5,739 Reduced 12.5%
40,159 $157,000
Q3 2021

Nov 12, 2021

SELL
$5.5 - $7.41 $137,962 - $185,872
-25,084 Reduced 35.34%
45,898 $302,000
Q2 2021

Aug 10, 2021

BUY
$4.35 - $6.35 $85,547 - $124,879
19,666 Added 38.32%
70,982 $437,000
Q1 2021

May 12, 2021

BUY
$3.94 - $7.09 $202,185 - $363,830
51,316 New
51,316 $232,000
Q4 2020

Feb 10, 2021

SELL
$5.45 - $8.65 $731,466 - $1.16 Million
-134,214 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.34 - $11.43 $581,794 - $1.53 Million
134,054 Added 83783.75%
134,214 $997,000
Q2 2020

Aug 13, 2020

SELL
$1.85 - $5.29 $55,783 - $159,509
-30,153 Reduced 99.47%
160 $1,000
Q1 2020

May 13, 2020

SELL
$1.24 - $4.35 $6,105 - $21,419
-4,924 Reduced 13.97%
30,313 $77,000
Q4 2019

Feb 10, 2020

SELL
$2.3 - $5.12 $7,359 - $16,384
-3,200 Reduced 8.33%
35,237 $123,000
Q3 2019

Nov 12, 2019

BUY
$4.63 - $12.15 $177,963 - $467,009
38,437 New
38,437 $178,000
Q4 2017

Feb 09, 2018

SELL
$4.46 - $6.45 $103,271 - $149,349
-23,155 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$3.55 - $5.49 $63,385 - $98,023
17,855 Added 336.89%
23,155 $117,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,300
5,300 $21,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.